Antisense oligonucleotides, antisense technology bio. Just as an increasing number of genetic causes of central nervous system cns diseases are being revealed, and genetic testing becomes more widely available, the potential for. Antisense oligonucleotides asos are known to trigger mrna degradation in the nucleus via an rnase hdependent mechanism. Although some of these mechanisms of inhibition have characterized, rigorous proof for others is still frequently lacking. Basic concepts and mechanisms find, read and cite all the research you. Chapters include oligonucleotide chemistry, dna triplex formation, delivery mechanisms, pharmocokinetics, toxicity, oligonucleotides. Antisense oligonucleotide strategy and molecule design. Here, we briefly summarize aspects of the chemistry and biology of antisense and sirna oligonucleotides that are salient to their potential as therapeutic agents. With these modifications, antisense oligonucleotides can. Food and drug administration, with full or conditional approval of vitravene, kynamro, exondys51, and spinraza. Antisense oligonucleotides or aso are shortchained dna sequences which are used to turn off genes. Although aso activity in the nucleus has been well demonstrated. The potential of antisense oligonucleotide therapies for. Rnasehmediated degradation of complementary mrna is the major mode of action of antisense oligonucleotides.
Antisense oligonucleotides can be used to target a specific, complementary coding or noncoding rna. Antisense oligonucleotides offer new opportunities for therapeutic intervention because they act inside the cell to influence protein production. Genes contain the information necessary to produce proteins. The concept underlying antisense technology is relatively straightforward. Guidelines for antisense oligonucleotide design and. Many genetic neurological diseases result from the dysfunction of single proteins. Antisense oligonucleotides inhibit intercellular adhesion. Asos exert their therapeutic effects in various ways depending on their chemical structure. Mechanism of action of antisense oligonucleotides asos. In addition, when antisense oligonucleotides were used to target an hdassociated snp in mice, there was a 50% decrease in the mutant huntingtin protein. Antisense oligonucleotides microsynth ag microsynth ch. An antisense oligonucleotide aso is a singlestranded deoxyribonucleotide, which is complementary to the mrna target. Mechanisms and strategies for effective delivery of antisense. Chromatography for the analysis of oligonucleotides.
Gene silencing is the regulation of gene expression in a cell to prevent the expression of a certain gene. Antisense oligonucleotides refer to short, synthetic oligonucleotide that are complementary in sequence and upon specific hybridization to its cognate gene product induces inhibition of gene expression. Although aso activity in the nucleus has been well demonstrated, the cytoplasmic activity of asos is less clear. Basic concepts and mechanisms, molecular cancer therapeutics, 2002, 1, 347. Pdf on apr 1, 2002, nathalie dias and others published antisense oligonucleotides. References in antisense therapy and emerging applications. The field of antisense oligonucleotide aso therapeutics has been around. These are synthetic singlestranded dna analogs, whose sequence is complementary to a target nucleotide and alter protein synthesis by several mechanisms. Oligonucleotides are in theory designed to specifically modulate the transfer of the genetic information to protein, but the mechanisms by which an oligonucleotide can induce a biological effect are subtle and complex. Journal of nanomaterials hindawi publishing corporation. Toxicology letters els evier toxicology letters 8283 1995 419424 antisense phosphorothioate oligodeoxynucleotides.
Basic concept and its therapeutic application article pdf available september 2014 with 1,482 reads how we measure reads. Antisense oligonucleotide an overview sciencedirect topics. We have now identified a putative cytoplasmic mechanism. Antisense oligonucleotides asos are used to inhibit gene expression levels both in vitro and in vivo. Historically, the effects of rna antisense technology have often been confused with those of rnaibased therapeutics because they both function as gene suppressors. Antisense oligonucleotides may be used to block the production of proteins needed for cell growth. Antisense oligonucleotides targeting angiogenic factors as. Antisense oligonucleotides are an emerging therapeutic option to treat diseases with known genetic origin. Antisense therapy is a form of treatment for genetic disorders or infections. In antisense technology short synthetic oligonucleotides are supposed to hybridize to a certain sequence of the mrna drug target thereby interfering with the mrna processing. Antisense oligonucleotides and other genetic therapies. We have now identified a putative cytoplasmic mechanism through which aso gapmers silence their targets when transfected or delivered gymnotically i. Alternative splicing, whereby different splice motifs and sites are recognised in a.
Antisense oligonucleotides have been used to modify the expression of specific genes. Antisense oligonucleotides asos are synthetically prepared short. Oligonucleotides incorporating 2omethoxyethyl moemodified nucleotides, can support most, if not all antisense mechanisms of action. Fundamental differences in the equilibrium considerations for sirna and antisense oligodeoxynucleotide design.
Clinical benefits of antisense oligonucleotides have been recognized by the u. If binding takes place this hybrid can be degraded by the enzyme rnase h. They are being studied in the treatment of several types of cancer. Using kinetic and subcellular fractionation studies, we evaluated aso activity in the cytoplasm. Nonallele specific gene silencing using sirna molecules has also been used to silence the mutant huntingtin proteins. Focusing on the predicted basic melting temperature t m. When the genetic sequence of a particular gene is known to cause a particular disease, it is possible to synthesize a strand of. There are several aspects of antisense therapy utilizing oligonucleotides that are potentially advantageous over traditional drug mechanisms. Ijms free fulltext systematic approach to developing. Methylenetetrahydrofolate reductase mthfr generates the folate. The recurring issues of target accessibility, probe design, offtarget effects and the proper use of chemical modifications are solved in the antisense architect which uses design heuristics that allows for the rational design of antisense oligonucleotides. Applied antisense oligonucleotide technology provides the basic concepts as well as the practical concerns associated with the use of antisense oligonucleotides to modify gene expression. Antisense oligonucleotides, such as sirna or antisense oligodeoxynucleotides odns, can silence gene expression 1. Rnases h is an enzyme that hydrolyzes rna, and when used in an antisense oligonucleotide application results in 8095% downregulation of mrna expression.
Protein production occurs in two phases called transcription and translation. Some groups have argued that rnai is one of the antisense mechanisms because the guide strand of the sirnashrna binds to the. Because a significant percentage of patients who require highdose statin therapy for dyslipidemia experience treatmentrelated muscle symptoms and an inconsistent clinical response, alternative or. Protein production occurs in two phases called transcription and. In those early days, there were constant supply chain delays, synthesis methods limited available quantities of drug substance, and analytical methods were poorly developed. Antisense oligonucleotides asos are short, synthetic, singlestranded oligodeoxynucleotides that can alter rna and reduce, restore, or modify protein expression through several distinct mechanisms. Stein1 columbia university, new york, new york 10032 conceptual simplicity, the possibility of rational.
They achieve this by mechanisms such as activating an enzyme rnase which cleaves mrna, by creating steric hindrance to the binding of mrna to ribosomes, or by disrupting ribosome machinery. Antisense oligonucleotides bind to nucleic acids in a sequencespecific manner by watsoncrick base pairing, and can affect the function of targeted mrnas and silence genes dias and stein, 2002. They achieve this by mechanisms such as activating an enzyme rnase. Crooke, md, phd, ceo of ionis pharmaceuticals and recipient of the 2016 lifetime achievement award from the oligonucleotide therapeutic society presents a detailed look at the. The process of premrna splicing is a common and fundamental step in the expression of most human genes. Antisense drugs are short, chemically modified, singlestranded nucleic acids antisense oligonucleotides that have the ability to target any gene product of interest. Synthetic antisense oligonucleotides asos are novel and efficient laboratory tools to regulate the expression of specific genes, and have only recently come into clinical use.
Here, the possibility of enhancing such processes at cellular and animal levels by cineole, as a penetration enhancer, was investigated. The basic idea of antisense oligonucleotide asobased therapy is to interrupt the flow of genetic. Antisense oligonucleotides oligonucleotidebased antisense techniques represent the most common and, to date, the most successful approach to achieving suppression or elimination of a genetic. Fundamental differences in the equilibrium considerations. It has been shown that endocytosis and interactions of liposomes with cytoplasmic and endosomal membranes are the main mechanisms for liposomal. Fundamental differences in the equilibrium considerations for. Guidelines for antisense oligonucleotide design and insight into splicemodulating mechanisms.
A more reliable technique is to reduce knockdown expression of the gene product, which can be achieved with rna interference therapies that use a cells own machinery for regulating protein expression or with antisense oligonucleotides aso. Rnase h1dependent antisense oligonucleotides are robustly. Many cancer lines are methionine dependent and decrease proliferation when methionine supply is limited. Chemistry, mechanism and clinical status of antisense. Many antisense oligonucleotides asos from several classes of molecules are currently in drug development. Main mechanisms of action of antisense oligonucleotides. Antisense oligonucleotides and other genetic therapies made. The field of antisense oligonucleotide aso therapeutics has been around since the early 1990s. Recent improvements in design and chemistry of antisense compounds have enabled this technology to become a routinely used tool in basic research, genomics, target validation, and drug discovery. In the age of personalised medicines, antisense oligonucleotides can sometimes.
We offer a widget that you can add to your website to let users look up cancerrelated terms. Mechanisms and strategies for effective delivery of. Basic concept and its therapeutic application 1dr bharti bhandari. In the age of personalised medicines, antisense oligonucleotides can sometimes be designed to target and bypass or overcome a patients genetic mutation, in particular those lesions that compromise normal premrna processing. Concepts and mechanisms cleotides, isis11158 and isis 11159, targeted to the 5. Antisense oligonucleotides oligonucleotidebased antisense techniques represent the most common and, to date, the most successful approach to achieving suppression or elimination of a genetic message. Rnase h1dependent antisense oligonucleotides asos are active in reducing levels of both cytoplasmic mrnas and nuclear retained rnas. The recurring issues of target accessibility, probe design, offtarget effects and the proper use of chemical modifications are solved in the antisense architect which uses.
However, although antisense oligonucleotides are commonly in. In the transcription phase, the dna strand is used as a template for manufacturing an mrna molecule. Second generation antisense oligonucleotides offer other mechanisms of action to inhibit the production of proteins thus having a potential an alternative antisense therapy to psodns. Antisense oligonucleotide therapy for spinocerebellar.
Oct 28, 2014 antisense drugs and oligonucleotides 1. Antisense oligonucleotides against atxn2 improved motor neuron function and restored firing frequency in cerebellar purkinje cells in mouse models of spinocerebellar ataxia type 2. The nci dictionary of cancer terms features 8,548 terms related to cancer and medicine. Targeted delivery of rnai therapeutics with endogenous and exogenous. The concept of using synthetic oligonucleotides to control the.
Gene silencing can occur during either transcription or translation and is often used in research. Feb 27, 2009 antisense oligonucleotides aons can interfere with mrna processing through rnase hmediated degradation, translational arrest, or modulation of splicing. The antisense approach relies on aons to efficiently bind to target sequences and depends. The antisense effect of a synthetic oligonucleotide sequence was first demonstrated in the late 1970s by zamecnik and stephenson 1. It is thought that by blocking the expression of selected proteins in signaling cascades, unwanted side effects may be avoided when using antisense oligonucleotides. Antisense oligonucleotides therefore are able to reduce the upstream signaling of protein expression and can concomitantly normalize the downstream expression of the targeted protein. The promise and the challenges from a toxicologic pathologists perspective. Second generation antisense oligonucleotides offer other mechanisms of action to inhibit the production of. Antisense oligonucleotides asos were first discovered to influence rna processing and modulate protein expression over two decades ago. Antisense oligonucleotides block translation of the mrna or induce its degradation by rnase h, while ribozymes and dna enzymes possess catalytic activity and cleave their target rna. Nci dictionary of cancer terms national cancer institute. Antisense technology an overview sciencedirect topics.
Conceptual simplicity, the possibility of rational design, relatively inexpensive cost, and developments in the sequencing of human genome have led to the use of short fragments of nucleic acid, commonly called oligonucleotides, either as therapeutic agents or as tools to study gene function. Basic mechanisms of action for therapeutic antisense oligonucleotides asos and rna interference rnai. The recent developments in the human genome sequencing, the possibility of a rational design of oligonucleotides and the theoretical simplicity. Microinjecting oligonucleotides into cells results in rapid accumulation of the oligonucleotide in the nucleus 7. Antisense oligonucleotides are synthetic polymers in which some or all of the natural nucleotide monomers of the oligonucleotide are chemicallymodified deoxynucleotides in dna or. Recent improvements in design and chemistry of antisense compounds have enabled this. Antisense oligonucleotides can alter gene expression through. Stein1 columbia university, new york, new york 10032 conceptual simplicity, the possibility of rational design, relatively inexpensive cost, and developments in the sequencing of human genome have led to the use of short fragments. Here, we briefly summarize aspects of the chemistry and biology of antisense and sirna oligonucleotides that are salient to their potential as therapeutic. The journal of biological chemistry 8 1991 by the american society for biochemistry and molecular biology, inc. Oct 30, 2015 antisense oligonucleotides asos are known to trigger mrna degradation in the nucleus via an rnase hdependent mechanism. Unraveling the mechanism of antisense oligonucleotides. A cytoplasmic pathway for gapmer antisense oligonucleotide. Chromatography for the analysis of oligonucleotides may 23.
Genetic therapies aim to modify these diseaseassociated proteins by targeting the rna and dna precursors. Despite over 20 years of pharmaceutical research, few asos have been marketed due to prob. Guidelines for antisense oligonucleotide design and insight. Further key distinctive characteristics are nuclease resistance, lower toxicity, superior target binding specificity, as well as increased affinity towards complementary rna. Antisense oligonucleotides integrated dna technologies. Cellular uptake and cytoplasmic release of liposomal antisense oligonucleotides asodns, which can act as ratelimiting steps, are still remained to be completely optimized. They achieve this by mechanisms such as activating an enzyme rnase which cleaves mrna, by. Gene therapy for parkinsons disease practical neurology.
196 1288 41 466 287 360 896 1031 588 312 17 190 99 13 1306 1575 1631 1604 478 794 671 1296 1541 650 180 825 1179 201 53 1552 1416 1059 1151 165 1483 914 539 8 839 230 1427 884